The gradual dose escalation, usually at 4-week intervals, helps minimize gastrointestinal adverse effects that commonly occur with GLP-1 receptor agonist therapy
The restriction of tight junctions between intestinal epithelial cells: The tight junctions between intestinal epithelial cells further limit the penetration of macromolecular protein drugs
Although inhibition of the COX-1 enzyme is thought to be the cause of adverse effects, such as gastric ulceration, even COX-2selective drugs have been associated with adverse effects, and safety in sick cats is not well evaluated
Additionally, GLP-1RAs facilitate the maintenance of endothelial barrier integrity, thus playing a crucial role in preventing vascular leakage.452 Endothelial cells exhibit enhanced NO production and concurrent suppression of endothelin formation, resulting in vascular smooth muscle relaxation and vasodilation mediated by the endothelium (e.g., GLP-1, exenatide, and liraglutide).453 Indeed, GLP-1RAs, including exenatide, liraglutide, and semaglutide, have been linked to the diminished expression of matrix metalloproteinases (MMPs).454,455,456 MMPs are a class of enzymes that play a crucial role in the breakdown of extracellular matrix components
If the side effects become bothersome or last longer than expected, its best to reach out to your healthcare provider for advice
Finally, after removing the magnetic ring from the pipette tip, the complexes were released in 300 L of 3,3,5,5-tetramethylbenzidine (TMB) solution by pipetting 10 times in the fourth well and incubated at room temperature for 15 min (Supplementary Movie S1)
